.

Biocryst Pharmaceuticals reported $417.48M in Cash and Equivalent for its second fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
DBV Technologies DBVT:US 21.3M 23.66M
Alnylam Pharmaceuticals ALNY:US $ 575.56M 41.48M
Biocryst Pharmaceuticals BCRX:US $ 417.48M 21.98M
Chemocentryx CCXI:US $ 44.4M 3.82M
Chugai Pharma 4519:JP Y 360311M 129837M
Daiichi Sankyo 4568:JP Y 658064M 4413M
Enanta Pharmaceuticals ENTA:US $ 28.37M 12.62M
Gilead Sciences GILD:US $ 7000M 2704M
GlaxoSmithKline GSK:LN 646500M 450200M
Glaxosmithkline GSK:US $ 6465M 4502M
Intra Cellular Therapies ITCI:US $ 77.24M 52.06M
IONIS PHARMACEUT IONS:US $ 521.92M 20.6M
Karyopharm Therapeutics KPTI:US $ 82.25M 71.01M
Mirati Therapeutics MRTX:US $ 245.51M 47.91M
Neurocrine Biosciences NBIX:US $ 163.3M 106.9M
Novavax NVAX:US $ 1375.59M 195.37M
Ptc Therapeutics PTCT:US $ 158.16M 13.98M
Regeneron Pharmaceuticals REGN:US $ 3395.1M 49.4M
Sarepta Therapeutics SRPT:US $ 868.56M 365.31M
Ultragenyx Pharmaceutical RARE:US $ 159.87M 5.88M
Vertex Pharmaceuticals VRTX:US $ 8702.2M 1102.1M
YTE INCY:US $ 2435.38M 178.62M